A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Little, Peter R; King, Vickie L; Davis, Kylie R; Cosgrove, Sallie B; Stegemann, Michael R

Little, Peter R; King, Vickie L; Davis, Kylie R; Cosgrove, Sallie B; Stegemann, Michael R.

Affiliation

Little PR; Veterinary Medicine Research and Development, Zoetis, 45 Poplar Road, Parkville, VIC, 3052, Australia.

Vet Dermatol ; 26(1): 23-30, e7-8, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25496303

Subject(s)

Cyclosporine/therapeutic use; Dermatitis, Atopic/veterinary; Dermatologic Agents/therapeutic use; Dog Diseases/drug therapy; Pyrimidines/therapeutic use; Sulfonamides/therapeutic use; Animals; Cyclosporine/adverse effects; Dermatitis, Atopic/complications; Dermatitis, Atopic/drug therapy; Dermatologic Agents/adverse effects; Dogs; Female; Male; Pruritus/etiology; Pruritus/veterinary; Pyrimidines/adverse effects; Single-Blind Method; Sulfonamides/adverse effects; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Cyclosporine / Dermatitis, Atopic / Dermatologic Agents / Dog Diseases Type of study: Etiology_studies Limits: Animals Language: En Journal: Vet Dermatol Journal subject: DERMATOLOGIA / MEDICINA VETERINARIA Year: 2015 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google